Search Results - "Woolf, E. J."

Refine Results
  1. 1

    Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid–liquid extraction and HPLC-MS/MS by Merschman, S.A., Vallano, P.T., Wenning, L.A., Matuszewski, B.K., Woolf, E.J.

    “…An HPLC-MS/MS method was developed for the determination of MK-0518 (raltegravir), an HIV integrase inhibitor, in human plasma over the concentration range of…”
    Get full text
    Journal Article
  2. 2

    Effect of the sample matrix on the determination of indinavir in human urine by HPLC with turbo ion spray tandem mass spectrometric detection by Fu, I, Woolf, E.J, Matuszewski, B.K

    “…The HPLC/tandem mass spectrometric (LC/MS/MS) behavior of indinavir, an HIV protease inhibitor, in human urine is presented as an example of a case where…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Determination of fexofenadine in human plasma using 96-well solid phase extraction and HPLC with tandem mass spectrometric detection by Fu, I., Woolf, E.J., Matuszewski, B.K.

    “…A fast and sensitive HPLC–MS/MS method, utilizing atmospheric pressure chemical ionization, for the determination of fexofenadine in human plasma is described…”
    Get full text
    Journal Article
  5. 5

    Determination of risedronate in human urine by column-switching ion-pair high-performance liquid chromatography with ultraviolet detection by Vallano, P.T, Shugarts, S.B, Kline, W.F, Woolf, E.J, Matuszewski, B.K

    “…An HPLC assay for the determination of risedronate in human urine was developed and validated. Risedronate and the internal standard were isolated from 5-ml…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Elimination of autosampler carryover in a bioanalytical HPLC-MS/MS method: a case study by Vallano, P.T., Shugarts, S.B., Woolf, E.J., Matuszewski, B.K.

    “…A case study in identifying and eliminating the source of autosampler carryover in a bioanalytical HPLC-MS/MS assay is described. Through a series of…”
    Get full text
    Journal Article
  8. 8

    Improved procedure for the the determination of rofecoxib in human plasma involving 96-well solid-phase extraction and fluorescence detection by Matthews, C.Z, Woolf, E.J, Matuszewski, B.K

    Published in Journal of Chromatography A (08-03-2002)
    “…An improved assay for the determination of rofecoxib in human plasma samples is described. The analyte and an internal standard were extracted from the plasma…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Determination of suvorexant in human plasma using 96-well liquid–liquid extraction and HPLC with tandem mass spectrometric detection by Breidinger, S.A., Simpson, R.C., Mangin, E., Woolf, E.J.

    “…•LC–MS/MS method for determination of suvorexant (MK-4305, Belsomra®) in human plasma.•The standard curve range was 1–1000ng/mL.•100μL of plasma was extracted…”
    Get full text
    Journal Article
  10. 10

    Simultaneous determination of unlabeled and carbon-13-labeled etoricoxib, a new cyclooxygenase-2 inhibitor, in human plasma using HPLC-MS/MS by Rose, M J, Agrawal, N, Woolf, E J, Matuszewski, B K

    Published in Journal of pharmaceutical sciences (01-02-2002)
    “…A method for the simultaneous determination of etoricoxib and its carbon-13 analog ((13)C(6)-etoricoxib) from human plasma has been developed and used to…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Simultaneous determination of omeprazole and 5′-hydroxyomeprazole in human plasma by liquid chromatography–tandem mass spectrometry by Woolf, E.J, Matuszewski, B.K

    Published in Journal of Chromatography A (18-12-1998)
    “…A method for the simultaneous determination of omeprazole and 5′-hydroxyomeprazole in human plasma is described. Isolation of the analytes from plasma was…”
    Get full text
    Journal Article Conference Proceeding
  13. 13
  14. 14

    Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans by Balani, S K, Woolf, E J, Hoagland, V L, Sturgill, M G, Deutsch, P J, Yeh, K C, Lin, J H

    Published in Drug metabolism and disposition (01-12-1996)
    “…Indinavir, N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-tertiary- butylaminocarbonyl-4-(3-pyridylmethyl)piperazino]-4(S)- hydroxy-2(R)-phenylmethylpentanamide…”
    Get more information
    Journal Article
  15. 15

    Monolithic silica liquid chromatography columns for the determination of cyclooxygenase II inhibitors in human plasma by Vallano, P.T, Mazenko, R.S, Woolf, E.J, Matuszewski, B.K

    “…Methods employing monolithic HPLC columns for the determination of the cyclooxygenase II inhibitors rofecoxib ( I) and…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Simultaneous determination of unlabeled and deuterium-labeled indinavir in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection by Woolf, E J, Matuszewski, B K

    Published in Journal of pharmaceutical sciences (01-02-1997)
    “…A method for the simultaneous determination of indinavir and its hexadeuterated analog (d6-indinavir) in human plasma is described. Isolation of the analytes…”
    Get more information
    Journal Article
  18. 18

    Dose Proportionality of Oral Etoricoxib, a Highly Selective Cyclooxygenase-2 Inhibitor, in Healthy Volunteers by Agrawal, Nancy G. B., Porras, Arturo G., Matthews, Catherine Z., Woolf, Eric J., Miller, Jutta L., Mukhopadhyay, Saurabh, Neu, Donald C., Gottesdiener, Keith M.

    Published in Journal of clinical pharmacology (01-10-2001)
    “…To assess dose proportionality of etoricoxib across the anticipated clinical dose range, a single panel of 12 healthy subjects was administered single oral…”
    Get full text
    Journal Article
  19. 19

    Isolation and structural characterization of the photolysis products of etoricoxib by Matthews, C Z, Subramanian, R, Woolf, E J, Foster, N, Matuszewski, B K

    Published in Pharmazie (01-12-2004)
    “…Etoricoxib is a potent and novel selective inhibitor of cyclooxygenase-2 (COX-2) which has been developed for the treatment of osteoarthritis, rheumatoid…”
    Get more information
    Journal Article
  20. 20

    Assessment of the in-vivo stereochemical integrity of aprepitant based on the analysis of human plasma samples via high-performance liquid chromatography with mass spectrometric detection by Kline, W. F., Woolf, E. J., Matuszewski, B. K.

    Published in Biomedical chromatography (01-09-2005)
    “…Achiral and chiral liquid chromatographic methods utilizing mass spectrometric detection were developed to investigate the possibility of inversion of…”
    Get full text
    Journal Article